Boxes of Covishield, the vaccine made at the Serum Institute of India, has left for multiple locations across India, Mr. Adar Poonawalla, CEO, SII, tweeted on Tuesday. “An emotional moment for the team at Serum Institute as the first shipments finally leave,” it said.
The Centre has procured 11 million doses at ₹200 a dose. Two doses, 28 days apart, are to be given to 30 crore healthcare workers and others in priority groups identified by States. As part of the government-sponsored inoculation of health workers, 5.5 million doses of Covaxin, developed by Bharat Biotech, are also being procured.
The SII had previously stated it had “stockpiled” 50 million doses. However, the government said on Tuesday that procurements would be staggered. After the first 100 million doses, the vaccine would be sold at ₹1000 a dose in private markets, Mr. Poonawalla said.
You have reached your limit for free articles this month.
Subscription Benefits Include
Today's Paper
Find mobile-friendly version of articles from the day's newspaper in one easy-to-read list.
Unlimited Access
Enjoy reading as many articles as you wish without any limitations.
Personalised recommendations
A select list of articles that match your interests and tastes.
Faster pages
Move smoothly between articles as our pages load instantly.
Dashboard
A one-stop-shop for seeing the latest updates, and managing your preferences.
Briefing
We brief you on the latest and most important developments, three times a day.
Support Quality Journalism.
*Our Digital Subscription plans do not currently include the e-paper, crossword and print.
A letter from the Editor
Dear subscriber,
Thank you!
Your support for our journalism is invaluable. It’s a support for truth and fairness in journalism. It has helped us keep apace with events and happenings.
The Hindu has always stood for journalism that is in the public interest. At this difficult time, it becomes even more important that we have access to information that has a bearing on our health and well-being, our lives, and livelihoods. As a subscriber, you are not only a beneficiary of our work but also its enabler.
We also reiterate here the promise that our team of reporters, copy editors, fact-checkers, designers, and photographers will deliver quality journalism that stays away from vested interest and political propaganda.
Suresh Nambath
